207 related articles for article (PubMed ID: 37030544)
1. Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation.
Gu Z; Hao Y; Schomann T; Ossendorp F; Ten Dijke P; Cruz LJ
J Control Release; 2023 May; 357():531-544. PubMed ID: 37030544
[TBL] [Abstract][Full Text] [Related]
2. Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4
Luo J; Pang S; Hui Z; Zhao H; Xu S; Yu W; Yang L; Sun Q; Hao X; Wei F; Wang J; Ren X
Theranostics; 2023; 13(14):4836-4857. PubMed ID: 37771774
[No Abstract] [Full Text] [Related]
3. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-based nano-micelles for potential anti-tumor immunotherapy: Synergistic effect of cGAS-STING signaling pathway activation and tumor antigen absorption.
Zhang S; Zeng Y; Wang K; Song G; Yu Y; Meng T; Yuan H; Hu F
Carbohydr Polym; 2023 Dec; 321():121346. PubMed ID: 37739513
[TBL] [Abstract][Full Text] [Related]
5. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
[TBL] [Abstract][Full Text] [Related]
6. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.
Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G
Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268
[TBL] [Abstract][Full Text] [Related]
7. Liposomal oxaliplatin prodrugs loaded with metformin potentiate immunotherapy for colorectal cancer.
Song L; Hao Y; Wang C; Han Y; Zhu Y; Feng L; Miao L; Liu Z
J Control Release; 2022 Oct; 350():922-932. PubMed ID: 36108810
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway.
Cheng L; Zhang P; Liu Y; Liu Z; Tang J; Xu L; Liu J
Biomaterials; 2023 Oct; 301():122259. PubMed ID: 37531777
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity.
Wang C; Zhang R; He J; Yu L; Li X; Zhang J; Li S; Zhang C; Kagan JC; Karp JM; Kuai R
Nat Commun; 2023 Jun; 14(1):3877. PubMed ID: 37391428
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment-responsive DNA-based nanomedicine triggers innate sensing for enhanced immunotherapy.
Li J; Han X; Gao S; Yan Y; Li X; Wang H
J Nanobiotechnology; 2023 Oct; 21(1):382. PubMed ID: 37858171
[TBL] [Abstract][Full Text] [Related]
11. Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response.
Shi F; Su J; Wang J; Liu Z; Wang T
Mol Cell Biochem; 2021 Feb; 476(2):1015-1024. PubMed ID: 33141310
[TBL] [Abstract][Full Text] [Related]
12. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
[TBL] [Abstract][Full Text] [Related]
13. Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy.
Yang L; Wang Y; Song Y; Li Z; Lei L; Li H; He B; Cao J; Gao H
J Control Release; 2024 May; 370():354-366. PubMed ID: 38685387
[TBL] [Abstract][Full Text] [Related]
14. Liposomal Delivery of MIW815 (ADU-S100) for Potentiated STING Activation.
Ji N; Wang M; Tan C
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839960
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.
Ohkuri T; Kosaka A; Ishibashi K; Kumai T; Hirata Y; Ohara K; Nagato T; Oikawa K; Aoki N; Harabuchi Y; Celis E; Kobayashi H
Cancer Immunol Immunother; 2017 Jun; 66(6):705-716. PubMed ID: 28243692
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin-/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer.
Shen F; Feng L; Zhu Y; Tao D; Xu J; Peng R; Liu Z
Biomaterials; 2020 Oct; 255():120190. PubMed ID: 32563943
[TBL] [Abstract][Full Text] [Related]
17. Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.
Limagne E; Thibaudin M; Nuttin L; Spill A; Derangère V; Fumet JD; Amellal N; Peranzoni E; Cattan V; Ghiringhelli F
Cancer Immunol Res; 2019 Dec; 7(12):1958-1969. PubMed ID: 31611243
[TBL] [Abstract][Full Text] [Related]
18. Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy.
Song W; Song SJ; Kuang J; Yang H; Yu T; Yang F; Wan T; Xu Y; Wei ST; Li MX; Xiong Y; Zhou Y; Qiu WX
ACS Nano; 2022 Oct; 16(10):15977-15993. PubMed ID: 36190834
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
[TBL] [Abstract][Full Text] [Related]
20. Curcumin/L-OHP co-loaded HAP for cGAS-STING pathway activation to enhance the natural immune response in colorectal cancer.
Xiao Y; Guo G; Wang H; Peng B; Lin Y; Qu G; Li B; Jiang Z; Zhang F; Wu J; Liang M
Bioeng Transl Med; 2024 Jan; 9(1):e10610. PubMed ID: 38193125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]